May 13, 2012 -- Over 700 industry leaders from the international biotech/pharma community are expected to converge on Suzhou, China for the ChinaBio® Partnering Forum 2012 on May 23–24; Mindray Medical bought a controlling stake in Hangzhou Optcla Medical Instrument, a medical device company specializing in endoscope and related surgical instruments; Zhejiang Hisun announced a strategic alliance with Enzon Pharma of the US to develop therapeutics using Enzon's Customized PEGylation Linker Technology; Zhejiang Huahai Pharma signed an agreement with Breckenridge Pharma allowing Breckenridge exclusive rights to distribute Huahai’s HIV drug Nevirapine in the US; and Shanghai Generon will begin a randomized, multi-center Phase II clinical trial in the US of its biologic treatment for breast cancer. More details…..
Stock Symbols: (NYSE: MR) (NSDQ: ENZN) (SHA: 600267) (SHE: 600521)
